Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report
- PMID: 37066051
- PMCID: PMC10091001
- DOI: 10.1159/000526349
Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report
Abstract
Introduction: Triple antibody positive antiphospholipid syndrome during pregnancy carries a poor prognosis. The placental vasculature is particularly vulnerable to these antibodies resulting in a marked increased risk of fetal growth restriction, placental infarction, abruption, stillbirth, and preterm severe preeclampsia.
Case presentation: We report a case of a primigravida with triple antibody positive antiphospholipid syndrome that demonstrated placental insufficiency and fetal compromise at a previable gestation. The patient underwent plasma exchange every 48 h for 11 weeks resulting in delivery of a viable infant. Placental blood flow was improved after complete absence of end-diastolic flow in the fetal umbilical artery.
Conclusion: Scheduled plasmapheresis every 48 h can be considered in select cases of antiphospholipid antibody syndrome.
Keywords: Antiphospholipid antibody syndrome; Low molecular weight heparin; Plasma exchange; Plasmapheresis; Pregnancy; Triple positive antibodies.
Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare. The views expressed in this submitted article are strictly the view of the authors and not an official position of the institution.
Figures
Similar articles
-
Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.Am J Obstet Gynecol. 2017 May;216(5):525.e1-525.e12. doi: 10.1016/j.ajog.2017.01.026. Epub 2017 Jan 30. Am J Obstet Gynecol. 2017. PMID: 28153662
-
Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients.Obstet Gynecol. 2003 Feb;101(2):258-63. doi: 10.1016/s0029-7844(02)02385-2. Obstet Gynecol. 2003. PMID: 12576248
-
Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.Biochem Pharmacol. 2020 Dec;182:114217. doi: 10.1016/j.bcp.2020.114217. Epub 2020 Sep 12. Biochem Pharmacol. 2020. PMID: 32926874
-
Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy.Eur J Obstet Gynecol Reprod Biol. 2004 Jun 15;114(2):125-9. doi: 10.1016/j.ejogrb.2003.09.040. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15140503 Review.
-
The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.Am J Obstet Gynecol. 2018 Feb;218(2S):S829-S840. doi: 10.1016/j.ajog.2017.11.565. Epub 2017 Dec 8. Am J Obstet Gynecol. 2018. PMID: 29229321 Review.
Cited by
-
Systemic Lupus Erythematosus Causing Rapid Progression of Mitral Valve Disease.JACC Case Rep. 2024 Aug 7;29(15):102429. doi: 10.1016/j.jaccas.2024.102429. eCollection 2024 Aug 7. JACC Case Rep. 2024. PMID: 39157550 Free PMC article.
References
-
- Baroni G, Banzato A, Bison E, Denas G, Zoppellaro G, Pengo V. The role of platelets in antiphospholipid syndrome. Platelets. 2017;28((8)):762–766. - PubMed
-
- James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29((3)):326–331. - PubMed
-
- Committee on Practice Bulletins – Obstetrics American College of Obstetricians and Gynecologists Practice bulletin No. 132: antiphospholipid syndrome. Obstet Gynecol. 2012;120((6)):1514–1521. - PubMed
Publication types
LinkOut - more resources
Full Text Sources